The Hydration Pharmaceuticals Co Ltd (ASX: HPC) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
The Hydration Pharmaceuticals Co Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$3.98 million
P/E Ratio
N/A
Dividend Yield
0.00%
Shares Outstanding
265.14 million
Earnings per share
-0.060
Dividend per share
N/A
Year To Date Return
-37.50%
Earnings Yield
N/A
Franking
-
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
The Hydration Pharmaceuticals Co Ltd (ASX: HPC)
Latest News
Opinions
"Bullish because everybody is bearish" – here are 8 dogs of 2022 I'm backing for the win in 2023
IPOs
Hydration Pharmaceuticals (ASX:HPC) share price rockets 31% in 2 days following IPO
HPC ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About The Hydration Pharmaceuticals Co Ltd
The Hydration Pharmaceuticals Co Ltd is engaged in the marketing and sale of liquid, tablet and powder hydration solution products into the North American markets of Canada and the United States. Some of its products include Hydration + Immune System Boost, Effervescent Electrolyte Tablets, Oral Rehydration Solution, and Immunity Booster Bundle.
HPC Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 02 May 2024 | $0.02 | $0.00 | 0.00% | 114,241 | $0.01 | $0.02 | $0.01 |
| 01 May 2024 | $0.01 | $0.00 | 0.00% | 415,738 | $0.01 | $0.01 | $0.01 |
| 29 Apr 2024 | $0.01 | $0.00 | 0.00% | 45,000 | $0.01 | $0.01 | $0.01 |
| 26 Apr 2024 | $0.01 | $0.00 | 0.00% | 9,241 | $0.01 | $0.01 | $0.01 |
| 23 Apr 2024 | $0.01 | $0.00 | 0.00% | 10,000 | $0.01 | $0.01 | $0.01 |
| 18 Apr 2024 | $0.01 | $0.00 | 0.00% | 608,229 | $0.01 | $0.01 | $0.01 |
| 12 Apr 2024 | $0.01 | $0.00 | 0.00% | 42,228 | $0.01 | $0.01 | $0.01 |
| 11 Apr 2024 | $0.01 | $0.00 | 0.00% | 27 | $0.01 | $0.01 | $0.01 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 02 Oct 2023 | Adem Karafili | Issued | 1,000,000 | $45,000 |
Rights issue.
|
| 02 Oct 2023 | Adem Karafili | Issued | 500,000 | $19,000 |
Rights issue.
|
| 02 Oct 2023 | Margaret Hardin | Issued | 166,667 | $6,333 |
Rights issue.
|
| 02 Oct 2023 | Margaret Hardin | Issued | 333,333 | $14,999 |
Rights issue.
|
| 20 Sep 2023 | George Livery | Issued | 277,778 | $10,833 |
Rights issue.
|
| 20 Sep 2023 | George Livery | Issued | 555,555 | $24,999 |
Rights issue.
|
| 08 Aug 2023 | Adem Karafili | Issued | 1,972 | $423 |
Issue of securities.
|
| 31 May 2023 | George Livery | Buy | 50,000 | $3,000 |
On-market trade.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr George Livery | Non-Executive ChairmanNon-Executive Director | Nov 2021 |
Mr Livery has enjoyed senior executive roles across numerous industries for the last 30 years, both domestically and internationally. A C-level executive for the last 25 years, George's career has included CEO of Village Cinemas Australia, COO of Village International, Commercial Director at Hoyts Ltd, Director of Operations (Non-Academic Services) at University of Sydney's USU, both Commercial Director at Swisse Vitamins and Director of Strategy & Corporate at Swisse Wellness Group. George also led the corporate integration of Swisse Wellness into the Hong Kong listed H&H Group of companies and enjoyed a dual role during that time as Group Senior VP Legal and Risk.
|
| Mr Adem Karafili | Non-Executive Director | Oct 2018 |
Mr Adem is the Chairman and founder of ANGL Korp, his investment vehicle for both ventures and investments. In his previous career, Adem was across a range of sectors and industries, having spent seven years establishing Swisse Wellness as the global health and wellness brand before it's sale to Biostime International for over $1.7bn. While at Swisse, Adem held senior positions of Chief Financial Officer, Chief Operating Officer, and Managing Director.
|
| Ms Margaret Hardin | Non-Executive Director | Feb 2022 |
Ms Hardin is a global products senior executive, with experience. She has previously scaled two consumer goods companies to generate more than US$100m in revenue, and currently advises founders on growth opportunities. Most recently, Ms Hardin was CEO of ERGObaby Carrier Inc. During her time with the group, she revived product innovation while managing an omni-channel distributor, retail, and ecommerce model across over 60 countries and 19 company-owned websites. Prior to ERGObaby Carrier Inc., Ms Hardin was CFO during the early stages of US baby and accessories company Munchkin and was progressively promoted to President and COO. She grew the company to a brand leader in the juvenile industry, where she led sales, acquisitions, brand partnerships and marketing efforts. She oversaw the opening of sales operations in Canada and launched the EMEA headquarters.
|
| Mr Oliver Baker | Chief Executive Officer |
-
|
|
| Ms Victoria Nadalin | Company Secretary | Feb 2023 |
-
|
| Chris Kavanaugh | CFO |
-
|
|
| Oliver Baker | Chief Executive Officer |
-
|
|
| Victoria Nadalin | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| J P Morgan Nominees Australia Pty Limited | 36,950,920 | 13.94% |
| Merrill Lynch (Australia) Nominees Pty Limited | 27,325,447 | 10.31% |
| Woobinda Nominees Pty Ltd <The Woobinda Family A/C> | 26,901,678 | 10.15% |
| HSBC Custody Nominees (Australia) Limited | 20,453,824 | 7.71% |
| Super Radek Pty Ltd <Super Radek Super Fund A/C> | 12,316,113 | 4.65% |
| Paul Orlin | 7,732,978 | 2.92% |
| 343 Pty Ltd <343 Capital A/C> | 7,126,416 | 2.69% |
| Binvid Pty Ltd <B&D Super Fund A/C> | 6,332,787 | 2.39% |
| Citicorp Nominees Pty Limited | 5,470,977 | 2.06% |
| BNP Paribas Nominees Pty Ltd <Ib Au Noms Retailclient> | 4,157,435 | 1.57% |
| Bw Equities Pty Ltd | 4,143,104 | 1.56% |
| Mr Carlo Chiodo | 2,941,553 | 1.11% |
| Ff Investments Nz Limited | 2,901,462 | 1.09% |
| Gowings Whale Fund Pty Ltd <Gowings Whale A/C> | 2,797,992 | 1.06% |
| Ankara Holdings Pty Ltd <The Ankara Family A/C | 2,562,389 | 0.97% |
| Tahmedia Pty Ltd | 2,329,307 | 0.88% |
| Ilwella Pty Ltd <No 2 A/C> | 2,300,000 | 0.87% |
| Netwealth Investments Limited <Wrap Services A/C> | 1,979,253 | 0.75% |
| Netwealth Investments Limited <Super Services A/C> | 1,968,166 | 0.74% |
| Richjac Pty Ltd | 1,843,263 | 0.70% |
